Literature DB >> 29904194

The market for oral anticoagulants.

Stephen Bielecki1, Dolim Lee1, Bashar Hamad1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29904194     DOI： 10.1038/nrd.2018.89

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.

Authors:  Stuart J Connolly; Truman J Milling; John W Eikelboom; C Michael Gibson; John T Curnutte; Alex Gold; Michele D Bronson; Genmin Lu; Pamela B Conley; Peter Verhamme; Jeannot Schmidt; Saskia Middeldorp; Alexander T Cohen; Jan Beyer-Westendorf; Pierre Albaladejo; Jose Lopez-Sendon; Shelly Goodman; Janet Leeds; Brian L Wiens; Deborah M Siegal; Elena Zotova; Brandi Meeks; Juliet Nakamya; W Ting Lim; Mark Crowther
Journal:  N Engl J Med       Date:  2016-08-30       Impact factor: 91.245

2.  Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban.

Authors:  Jack E Ansell; Sasha H Bakhru; Bryan E Laulicht; Solomon S Steiner; Michael A Grosso; Karen Brown; Victor Dishy; Hans J Lanz; Michele F Mercuri; Robert J Noveck; James C Costin
Journal:  Thromb Haemost       Date:  2016-11-17       Impact factor: 5.249
  2 in total
  5 in total

1.  Sulfonylureas and Metformin Were Not Associated With an Increased Rate of Serious Bleeding in Warfarin Users: A Self-Controlled Case Series Study.

Authors:  Young Hee Nam; Xu Han; Colleen M Brensinger; Warren B Bilker; Charles E Leonard; Sean Hennessy
Journal:  Clin Pharmacol Ther       Date:  2020-05-31       Impact factor: 6.875

2.  A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting.

Authors:  Galit H Frydman; Felix Ellett; Elizabeth M Van Cott; Douglas Hayden; Maulik Majmudar; Charles R Vanderburg; Haley Dalzell; Divya L Padmanabhan; Nick Davis; Julianne Jorgensen; Mehmet Toner; James G Fox; Ronald G Tompkins
Journal:  Crit Care Explor       Date:  2019-08-20

3.  Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies.

Authors:  Cheng-Cheng Shi; Tian-Ran Chen; Qi-Hua Zhang; Ling-Hua Wei; Chao Huang; Ya-Di Zhu; Hai-Bin Liu; Ya-Kun Bai; Fang-Jun Wang; Wen-Zhi Guo; Li-Rong Zhang; Guang-Bo Ge
Journal:  RSC Adv       Date:  2020-01-22       Impact factor: 4.036

Review 4.  Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.

Authors:  Ashis K Mukherjee; Dhruba J Chattopadhyay
Journal:  Phytother Res       Date:  2022-02-11       Impact factor: 6.388

5.  Efficacy and Safety of Clinically Driven Low-Dose Treatment with Direct Oral Anticoagulants in Asians with Atrial Fibrillation: a Systematic Review and Meta-analysis.

Authors:  Jillie Choi; Jae Eun No; Ju-Yeun Lee; Soo An Choi; Woo-Young Chung; Young-Mi Ah; Yun Mi Yu
Journal:  Cardiovasc Drugs Ther       Date:  2021-03-16       Impact factor: 3.727
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.